Full Length Research Paper
References
|
Alamuri P, Eaton KA, Himpsl SD, Smith SN, Mobley HL (2009). Vaccination with proteus toxic agglutinin, a hemolysin-independent cytotoxin in vivo, protects against Proteus mirabilis urinary tract infection. Infect. Immun. 77(2):632-641. |
|
|
Allison C, Emödy L, Coleman N, Hughes C (1994). The role of swarm cell differentiation and multicellular migration in the uropathogenicity of Proteus mirabilis. J. Infect. Dis. 169(5):1155-1158. |
|
|
Armbruster CE, Mobley HLT (2012). Merging mythology and morphology: the multifaceted lifestyle of Proteus mirabilis. Nat. Rev. Microbiol. 10(11):743-754. |
|
|
Assmann TS, Brondani Lde A, Bouças AP, Canani LH, Crispim D (2015). Toll-like receptor 3 (TLR3) and the development of type 1 diabetes mellitus. Arch. Endocrinol. Metab. 59(1):4-12. |
|
|
Cernohorská L, Votava M (2008). Antibiotic synergy against biofilm-forming Pseudomonas aeruginosa. Folia Microbiol. 53(1):57-60. |
|
|
Chakraborti AK, Garg SK, Kumar R, Motiwala HF, Jadhavar PS (2010). Progress in COX-2 inhibitors: a journey so far. Curr. Med. Chem. 17(15):1563-1593. |
|
|
De Kievit TR, Gillis R, Marx S, Brown C, Iglewski BH (2001). Quorum-sensing genes in Pseudomonas aeruginosa biofilms: their role and expression patterns. Appl. Environ. Microbiol. 67(4):1865-1873. |
|
|
Flannery EL, Mody L, Mobley HLT (2009). Identification of a modular pathogenicity island that is widespread among urease-producing uropathogens and shares features with a diverse group of mobile elements. Infect Immun. 77:4887-4894. |
|
|
Gómez-Suárez C, Pasma J, van der Borden AJ, Wingender J, Flemming HC, Busscher HJ, van der Mei HC (2002). Influence of extracellular polymeric substances on deposition and redeposition of Pseudomonas aeruginosa to surfaces. Microbiology 148(4):1161-1169. |
|
|
Grayson ML (1995). Diabetic foot infections, Antimicrobial therapy. Infect Dis Clin North Am. 9:143-161. |
|
|
Hegazy WA, Hensel M (2012). Salmonella enterica as a vaccine carrier. Future Microbiol. 7(1):111-127. |
|
|
Jacobsen SM, Stickler DJ, Mobley HLT, Shirtliff ME (2008). Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin. Microbiol. Rev. 21:26-59. |
|
|
Jones SM, Yerly J, Hu Y, Ceri H, Martinuzzi R (2007). Structure of Proteus mirabilis biofilms grown in artificial urine and standard laboratory media. FEMS Microbiol. Lett. 268:16-21. |
|
|
Keay L, Moser PW, Wildi BS (1970). Proteases of the genus Bacillus. II. Alkaline proteases. Biotechnol. Bioeng. 12(2):213-249. |
|
|
Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC (1997). Color atlas and textbook of diagnostic microbiology. Lippincott, Philadelphia 5th ed: pp. 253-320. |
|
|
Liaw SJ, Lai HC, Ho SW, Luh KT, Wang WB (2001). Characterization of p-nitrophenylglycerol-resistant Proteus mirabilis super-swarming mutants. J. Med. Microbiol. 50(12):1039-1048. |
|
|
Liaw SJ, Lai HC, Wang WB (2004). Modulation of swarming and virulence by fatty acids through the RsbA protein in Proteus mirabilis. Infect. Immun. 72(12):6836-6845. |
|
|
Loomes LM, Senior BW, Kerr M (1990). A proteolytic enzyme secreted by Proteus mirabilis degrades immunoglobulins of the immunoglobulin A1 (IgA1), IgA2, and IgG isotypes. Infect. Immun. 58(6):1979-1985. |
|
|
Mackay ML, Milne K, Gould IM (2000). Comparison of methods for assessing synergic antibiotic interactions. Int J Antimicrob Agents. 15(2):125-129. |
|
|
Mobley HL, Island MD, Hausinger RP (1995). Molecular biology of microbial ureases. Microbiol. Rev. 59(3):451-480. |
|
|
Morgenstein RM, Szostek B, Rather PN (2010). Regulation of gene expression during swarmer cell differentiation in Proteus mirabilis. FEMS Microbiol. Rev. 34(5):753-763. |
|
|
O'Hara CM, Brenner FW, Miller JM (2000) Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clin Microbiol. Rev. 13:534-546. |
|
|
Park TH, Anand A (2015). Management of diabetic foot: Brief synopsis for busy orthopedist. J. Clin. Orthop. Trauma 6(1):24-29. |
|
|
Pearson MM, Sebaihia M, Churcher C, Quail MA, Seshasayee AS, Luscombe NM, Abdellah Z, Arrosmith C, Atkin B, Chillingworth T, Hauser H, Jagels K, Moule S, Mungall K, Norbertczak H, Rabbinowitsch E, Walker D, Whithead S, Thomson NR, Rather PN, Parkhill J, Mobley HL (2008). Complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility. J. Bacteriol. 190(11):4027-4037. |
|
|
Perim MC, Borges JC, Celeste SR, Orsolin EF, Mendes RR, Mendes GO, Ferreira RL, Carreiro SC, Pranchevicius MC (2015). Aerobic bacterial profile and antibiotic resistance in patients with diabetic foot infections. Rev. Soc Bras. Med. Trop. 48(5):546-554. |
|
|
Rather PN (2005). Swarmer cell differentiation in Proteus mirabilis. Environ. Microbiol. 7:1065-1073. |
|
|
Rózalski A, Sidorczyk Z, KoteÅ‚ko K (1997). Potential virulence factors of Proteus bacilli. Microbiol. Mol. Biol. Rev. 61(1):65-89. |
|
|
Santema TB, Poyck PP, Ubbink DT (2016). Skin grafting and tissue replacement for treating foot ulcers in people with diabetes. Cochrane Database Syst Rev. 11;2:CD011255. |
|
|
Sekhar S, Vyas N, Unnikrishnan M, Rodrigues G, Mukhopadhyay C (2014). Antimicrobial susceptibility pattern in diabetic foot ulcer: a pilot study. Ann. Med. Health Sci. Res. 4(5):742-745. |
|
|
Senior BW (1993). The production of HlyA toxin by Proteus penneri strains. J. Med. Microbiol. 39(4):282-289. |
|
|
Stepanovic S, Vukovic D, Dakic I, Savic B, Svabic-Vlahovic M (2000). A modified microtiter-plate test for quantification of Staphylococcal biofilm formation. J. Microbio.l Methods. 40(2):175-9. |
|
|
Tansarli GS, Athanasiou S, Falagas ME (2013). Evaluation of Antimicrobial Susceptibility of Enterobacteriaceae Causing Urinary Tract Infections in Africa. Antimicrob. Agents Chemother. 57(8):3628-2639. |
|
|
Vesterlund S, Paltta J, Karp M, Ouwehand AC (2005). Measurement of bacterial adhesion-in vitro evaluation of different methods. J. Microbiol. Methods. 60(2):225-233. |
|
|
Wayne PA (2006). Clinical and Laboratory Standards Institute Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 7th ed. CLSI Document M7-A7. |
|
|
Zhang W, Li C (2016). Exploiting Quorum Sensing Interfering Strategies in Gram-Negative Bacteria for the Enhancement of Environmental Applications. Front. Microbiol. 8(6):1535. |
|
|
Zhao WH, Hu ZQ (2013). Epidemiology and genetics of CTX-M extended-spectrum β-lactamases in Gram-negative bacteria. Crit. Rev. Microbiol. 39(1):79-101. |
|
Copyright © 2025 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
